Chang et al., 1996 - Google Patents
Murine models for the evaluation of anti-HIV strategiesChang et al., 1996
- Document ID
- 5317780053044103718
- Author
- Chang L
- Zhang C
- Robinson D
- Dickie P
- Publication year
- Publication venue
- Transfusion Science
External Links
Snippet
Human immunodeficiency virus (HIV) infection is almost always pathogenic in humans and there is no effective therapy to counter its lethal consequences. The therapeutic application of conventional anti-viral drugs (RT and protease inhibitors) has resulted in limited success …
- 230000036436 anti-hiv 0 title description 28
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0273—Cloned animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bevec et al. | Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. | |
| US6495349B1 (en) | Chimeric gene constructs | |
| Strayer et al. | Current status of gene therapy strategies to treat HIV/AIDS | |
| AU651311B2 (en) | Recombinant retroviruses | |
| EP0845537A1 (en) | Recombinant retroviruses delivering vector constructs to target cells | |
| JPH04505261A (en) | Stably transformed eukaryotic cells containing transcribable foreign DNA under the control of a Pol III promoter | |
| RU2301260C2 (en) | Viral vectors with condition-dependent replication and their using | |
| Klotman et al. | Transgenic models of HIV-1 | |
| JP2005520482A (en) | Improved conditional replication vector to inhibit viral infection | |
| CA2158252A1 (en) | Delivery system controlled through factors associated with hiv and cell | |
| Chang et al. | Murine models for the evaluation of anti-HIV strategies | |
| Amado et al. | Gene therapy for the treatment of AIDS: animal models and human clinical experience | |
| Ruprecht et al. | Murine models for evaluating antiretroviral therapy | |
| RUPRECHT et al. | Development of antiviral treatment strategies in murine models | |
| WO1995008635A1 (en) | Expression of viral decoy proteins under the control of a locus control region and uses thereof | |
| AU689799B2 (en) | Recombinant retroviruses | |
| JP2004201546A (en) | Human immunodeficiency virus type 1 (hiv-1)-infected model animal | |
| Peng | Intracellular immunization with a dual-functionantitat gene against human immunodeficiency virus type 1 | |
| Paul | Development of transgenic mouse models to study HIV-1 replication | |
| MEHROTRA et al. | USE OF GENE THERAPY TO CURE AIDS | |
| Poluektova | K. Sato Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, 53 Shogoinkawara-cho, Sakyo-ku, Kyoto 6068507, Japan e-mail: ksato@ virus. kyoto-u. ac. jp© Springer Science+ Business Media New York 2014 | |
| Li | Use of retroviral vectors in studying gag-specific CTL in cats infected with feline immunodeficiency virus | |
| Gardner | AIDS MODELS |